[
{
"name": "Related Stories / Support Us Combo",
"component": "12278355",
"insertPoint": "4",
"requiredCountToDisplay": "6"
},{
"name": "Air - Billboard - Inline Content",
"component": "12278351",
"insertPoint": "2/3",
"requiredCountToDisplay": "7"
},
{
"name": "Air - MediumRectangle - Inline Content - Mobile Display Size 2",
"component": "12278352",
"insertPoint": "12",
"requiredCountToDisplay": "12"
},{
"name": "Air - MediumRectangle - Inline Content - Mobile Display Size 2",
"component": "12278352",
"insertPoint": "4th",
"startingPoint": "16",
"requiredCountToDisplay": "12"
}
,{
"name": "RevContent - In Article",
"component": "13536732",
"insertPoint": "3/5",
"requiredCountToDisplay": "5"
}
]
Is the University of Miami crazy? Well, if they are don't be surprised if their new psychiatrist pumps them full of lots and lots of GlaxoSmithKline pills.
psychiatry department. Nemeroff is an internationally known expert on depression, unfortunately he's also widely known for a bit of deception.
While head of Emory University's psychiatry department he failed to report $800,000 he was given for speaking fees from drug company GlaxoSmithKline.
Since 2000, Nemeroff had taken more than $2.8 million from drug companies. That's the company that makes anti-depressants like Paxil and Wellbutrin, and his ties to the company presented a conflict of interest. Criticism even extended to the Senate
where he was taken to task by Sen. Chuck Grassley.
